Medipharm Labs Corporation (OTCMKTS: MEDIF) has announced the completion of all payments necessary as per the 2020 $41 million unsecured convertible debt. The company specializes in...
MediPharm Labs Corp (OTCMKTS: MEDIF) announced financial results for the quarter and nine months ending September 30, 2021, which was a transition period for the company...
Medipharm Labs Corporation (OTCMKTS:MEDIF) has announced the expansion of its innovative Pharma-quality family branded products with the launch of THC 30, CBD 100, and its first...
Medipharm Labs Corporation (OTCMKTS:MEDIF) has announced that MediPharm Labs and Societe Quebecois Du Cannabis (SQDC) have signed a distribution supply agreement for the supply of cannabis...
Medical Cannabis by Shoppers Inc (MCS) and UHN (University Health Network) selected Medipharm Labs Corp (OTCMKTS:MEDIF) to track the medical-use cannabis products using blockchain technology. VP...
Medipharm Labs Corp (OTCMKTS:MEDIF)’s auxiliary unit MediPharm Labs Australia (Medipharm), entered a supply pact with VIVO Cannabis Inc (OTCMKTS:VVCIF)’s subsidiary – Beacon Medical Australia Pty. Ltd...
Medipharm Labs Corp (OTCMKTS:MEDIF) has launched its CBD50 Plus Formula (“CBD50”), in a move aimed at accelerating its growth of pharma-quality product portfolio. CBD50 Plus is uniquely...
MediPharm Labs Corp (OTCMKTS:MEDIF) has announced the signing of a strategic multifaceted manufacturing deal with Avicanna Inv. (OTCMKTS:AVCNF) that involves international and domestic distribution, licensed production...
Medipharm Labs Corp (OTCMKTS:MEDIF) will supply pharmaceutical quality cannabis oil products in Australia. It is on the backdrop of a two-year agreement signed between Compass Clinics...
Medipharm Labs Corp (OTCMKTS:MEDIF) has completed the first shipment under a cannabis 2.0 accord with 1193269 B.C. Ltd. The company is offering high-quality cannabis extracts and...